Generic Jakloc 5 is a generic medication formulated with the active ingredient Tofacitinib, primarily used for the management of rheumatoid arthritis and other inflammatory conditions.

Description Jakloc 5, containing the active substance Tofacitinib, is a medication designed to treat autoimmune conditions by inhibiting Janus kinase pathways, which are crucial in the inflammatory process of diseases like rheumatoid arthritis.

Benefits The primary benefit of Jakloc 5 is its ability to reduce inflammation and manage symptoms of rheumatoid arthritis, improving joint function and reducing pain.

Ingredients The main ingredient in Jakloc 5 is Tofacitinib, a Janus kinase inhibitor that helps modulate the immune system and reduce inflammation.

Uses and Doses Jakloc 5 is used for treating moderately to severely active rheumatoid arthritis, with a typical dosage of 5 mg twice daily or adjusted based on medical advice for specific cases.

Side Effects Common side effects include upper respiratory tract infections, headaches, diarrhea, and nasopharyngitis. More serious adverse reactions can include severe infections and liver enzyme abnormalities.

How to Use Jakloc 5 should be taken as prescribed by a healthcare provider, with doses typically administered twice daily. It can be taken with or without food.

Pregnancy & Lactation Jakloc 5 should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not recommended for use while breastfeeding.

Precautions and Warnings Patients should be monitored for infections, changes in blood counts, and liver function. Jakloc 5 should not be used with live vaccines or during active infections.

Safety Information Jakloc 5 requires careful monitoring of blood parameters and liver function. It is also important to avoid live vaccines during treatment.

Indications Jakloc 5 is indicated for treating rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis when other treatments have failed.

Pharmacology Tofacitinib, the active ingredient in Jakloc 5, inhibits the JAK-STAT signaling pathway, reducing inflammatory cytokine activity and controlling autoimmune disease progression.

Therapeutic Class Jakloc 5 belongs to the immunosuppressant class, specifically targeting the Janus kinase (JAK) pathways involved in immune and inflammatory responses.

Storage Conditions Store Jakloc 5 in a cool and dry place, away from light and moisture, at temperatures below 30°C.

FAQs

1. Can Jakloc 5 be taken with other medications?
2. What should I do if I miss a dose of Jakloc 5?
3. Are there any dietary restrictions while taking Jakloc 5?

Disclaimer

This information is provided without any warranties and should not replace advice from your healthcare provider.

Keywords:  Jakloc 5, Tofacitinib, rheumatoid arthritis, immunosuppressant, JAK inhibitor, anti-inflammatory, psoriatic arthritis, ulcerative colitis, medication, healthcare, treatment, dosage, side effects, precautions, safety, pregnancy, lactation, pharmacology, therapeutic class, storage, prescription, autoimmune disease.